In large cardiovascular (CV) outcome trials of patients with type 2 diabetes (T2D), sodium–glucose co-transporter 2 (SGLT2) inhibitors have demonstrated beneficial effects on CV outcomes. These results have been presented in a recent ESC conference and published on...
You are invited to participate in a new Delphi Survey to understand what outcomes are important to patients, caregivers, family members and health professionals for research (clinical trials) in people with chronic kidney disease. This will help to ensure that...
GENERAL ASSEMBLY OF THIS ENTITY On the morning of Tuesday 3 the General Assembly of this entity was held, where the annual accounts, the 2019 report and the plan for the year 2020 and the budget for the same year were approved. EKHA is the reference organization in...
EL CONGRESO EUROPEO DE PACIENTES APUESTA POR LA PARTICIPACIÓN DEL PACIENTE EN TODO LO RELATIVO A SU SALUD On November 12, 13 and 14, the first European Congress of patient entities is taking place in Brussels, where different European Patient Defense institutions are...
EUROPEAN SUMMIT ON ANTI-INFECTIVE THERAPIES IN AMSTERDAM The resistance to antibiotic and antifungal products is increasingly worrying, something that is aggravated in chronic patients who, like the renal ones, are usually immunocompromised and, thus, have an...
